Downloaded from: justpaste.it/2jpni
Vaccine firms Bharat Biotech, Serum Institute patch up after war of words Adar Poonawalla and Krishna Ella issue joint statement saying they would work together to roll out Covid19 vaccine
After engaging in a war of words, the chiefs of two of India’s leading vaccine makers — Bharat Biotech and Serum Institute of India (SII) — called a truce on Tuesday and pledged to work together for a “smooth roll-out” of Covid-19 vaccines. In a joint statement, Bharat Biotech Chairman and Managing Director Krishna Ella and SII Chief Executive Officer Adar Poonawalla said the more important task in front of them was to save the lives and livelihoods of populations in India and the world. “Vaccines are a global public health good and they have the
power to save lives and accelerate the return to economic normalcy at the earliest,” the statement read. “Now that two Covid-19 vaccines have been issued EUA (emergency use authorisation) in India, the focus is on manufacturing, supply, and distribution…Both companies are fully engaged in this activity and consider it our duty to the nation and the world at large to ensure a smooth roll-out of vaccines,” it said. Poonawalla had tweeted about releasing a joint statement earlier in the day, while Bharat Biotech put out the statement on its Twitter handle…